6919 KangPei Biotech Board Re-election Announcement

Announcement Date: May 23, 2026. Statement Date: May 22, 2026. Company Code: 6919. Company Name: KangPei Biotech. Subject: Announcement of the re-election of directors (including independent directors) at the 2026 Annual General Meeting. Fact Date: May 22, 2026. Explanation: 1. Change Date: May 22, 2026. 2. Personnel Category: Directors and Independent Directors. 3. Former Personnel: (1) Director: Xu Lu-Hui, (2) Director: Ling Yu-Fang, (3) Director: Chiu Chuan-Cheng, (4) Director: Chang Kao-Jung, (5) Independent Director: Kuo Pu-Jen, (6) Independent Director: Lin Ching-Po, (7) Independent Director: Peng Hsien-Li. 4. Former Background: Xu is Chairman and Chief Strategy Officer of KangPei, Ling is CEO and R&D Head, Chiu is Director of Yi-Ding-Xing Tech, Chang is Director of Chi-Se-Jia Clinic, Kuo is Finance Manager of Zhong-Wan, Lin is Distinguished Professor at NYCU, Peng is Director of Peng Hsien-Li Dermatology Clinic. 5. New Personnel: (1) Director: Xu Lu-Hui, (2) Director: Ling Yu-Fang, (3) Director: Chiu Chuan-Cheng, (4) Director: Chang Kao-Jung, (5) Independent Director: Lin Ching-Po, (6) Independent Director: Luo Bao-Zhu, (7) Independent Director: Peng Hsien-Li. 6. New Background: Luo serves as an independent director at Yung-Hong Biotech and PharmaEngine. 7. Reason: Full re-election due to term expiration. 8. Shareholdings at election: Xu 107,541,980 shares, Ling 152,297,260 shares, Chiu 17,199,060 shares, Chang 17,600,080 shares, Lin 29,000 shares, Luo 0 shares, Peng 0 shares. 9. Effective Date: May 22, 2026. 10. Other: Does not constitute a change of more than one-third of the board.